Resultaten van semencryopreservatie en gebruik voor kunstmatige voortplantingstechnieken bij 898 mannen met kanker: Semencryopreservatie bij mannen met kanker

Translated title of the contribution: Results of cryopreserved semen and its use for assisted reproduction technology in 898 men with cancer

I. Muller, R. J A Oude Ophuis, F. J M Broekmans, M. T W T Lock*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Laparoscopic radical cystectomy in a non-academic center by a single surgeon in 94 cases Objective:: To determine how often cryopreserved semen from cancer patients is used and the success rate of assisted reproductive technology (ART) in this group. Design:: Retrospective data analysis. Setting:: Academic tertiary referral fertility centre. Patients:: 898 male cancer patients who cryopreserved semen between 1983-2013. Intervention:: Follow-up of all ART treatments. Main outcome measures:: Usage rate of cryopreserved semen and success rate of assisted reproductive technology in achieving parenthood. Results:: 898 patients cryobanked their semen. 96 patients used their cryopreserved semen for ART (10,7%). The clinical pregnancy rate for intra-uterine insemination (IUI), in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI) and cryo embryo transfer (ET) were 14%, 37%, 38% and 18%, respectively. A total of 77% of the couples achieved parenthood. Conclusions:: Although the success rates of ART are impressive, the usage rate of cryopreserved semen in cancer patients is (too) low.

Translated title of the contributionResults of cryopreserved semen and its use for assisted reproduction technology in 898 men with cancer
Original languageDutch
Pages (from-to)120-126
Number of pages7
JournalTijdschrift voor Urologie
Volume5
Issue number5
DOIs
Publication statusPublished - 28 Sept 2015

Keywords

  • cryopreservation
  • semen
  • cancer
  • assisted reproduction technology

Fingerprint

Dive into the research topics of 'Results of cryopreserved semen and its use for assisted reproduction technology in 898 men with cancer: Semencryopreservatie bij mannen met kanker'. Together they form a unique fingerprint.

Cite this